Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yair Gazitt & Cagla Akay. (2005) Arsenic trioxide: An anti cancer missile with multiple warheads. Hematology 10:3, pages 205-213.
Read now
Read now
Markus Thomas Rojewski, Sixten Körper & Hubert Schrezenmeier. (2004) Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside. Leukemia & Lymphoma 45:12, pages 2387-2401.
Read now
Read now
Suk-Hyun Hong, Zhihong Yang & Martin L. Privalsky. (2001) Arsenic Trioxide Is a Potent Inhibitor of the Interaction of SMRT Corepressor with Its Transcription Factor Partners, Including the PML-Retinoic Acid Receptor α Oncoprotein Found in Human Acute Promyelocytic Leukemia. Molecular and Cellular Biology 21:21, pages 7172-7182.
Read now
Read now
Shang-Yi Huang, Chih-Hsin Yang & Yao-Chang Chen. (2000) Arsenic Trioxide Therapy for Relapsed Acute Promyelocytic Leukemia: an Useful Salvage Therapy. Leukemia & Lymphoma 38:3-4, pages 283-293.
Read now
Read now
Articles from other publishers (67)
Claudia Chiriches, Nathalie Nicolaisen, Maria Wieske, Heba Elhaddad, Ecmel Mehmetbeyoglu, Caroline Alvares, Dörte Becher, Paul Hole, Oliver Gerhard Ottmann & Martin Ruthardt. (2022) Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. PLOS Genetics 18:10, pages e1010463.
Crossref
Crossref
Filipe R. M. B. Oliveira, Ericks S. Soares, Christoph Harms, Helena I. Cimarosti & Regina Sordi. (2022) SUMOylation in peripheral tissues under low perfusion‐related pathological states. Journal of Cellular Biochemistry 123:7, pages 1133-1147.
Crossref
Crossref
Qian Nie, Huimin Chen, Ming Zou, Ling Wang, Min Hou, Jia-Wen Xiang, Zhongwen Luo, Xiao-Dong Gong, Jia-Ling Fu, Yan Wang, Shu-Yu Zheng, Yuan Xiao, Yu-Wen Gan, Qian Gao, Yue-Yue Bai, Jing-Miao Wang, Lan Zhang, Xiang-Cheng Tang, Xuebin Hu, Lili Gong, Yizhi Liu & David Wan-Cheng Li. (2021) The E3 Ligase PIAS1 Regulates p53 Sumoylation to Control Stress-Induced Apoptosis of Lens Epithelial Cells Through the Proapoptotic Regulator Bax. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Biying Zhao, Zhenzhen Zhang, Xu Chen, Yajie Shen, Yuanyuan Qin, Xinyi Yang, Zhengcao Xing, Shanshan Zhang, Xiaojun Long, Yuhong Zhang, Siming An, Hongmei Wu & Yitao Qi. (2020) The important roles of protein SUMOylation in the occurrence and development of leukemia and clinical implications. Journal of Cellular Physiology 236:5, pages 3466-3480.
Crossref
Crossref
Fang‐Yuan Liu, Jia‐Ling Fu, Ling Wang, Qian Nie, Zhongwen Luo, Min Hou, Yuan Yang, Xiao‐Dong Gong, Yan Wang, Yuan Xiao, Jiawen Xiang, Xuebin Hu, Lan Zhang, Mingxing Wu, Weirong Chen, Bing Cheng, Lixia Luo, Xinyu Zhang, Xialin Liu, Danying Zheng, Shengsong Huang, Yizhi Liu & David Wan‐Cheng Li. (2020) Molecular signature for senile and complicated cataracts derived from analysis of sumoylation enzymes and their substrates in human cataract lenses. Aging Cell 19:10.
Crossref
Crossref
S.M. Baba, A.A. Pandith, Z.A. Shah & R.A. Baba. (2018) Pathogenetic implication of fusion genes in acute promyelocytic leukemia and their diagnostic utility. Clinical Genetics 95:1, pages 41-52.
Crossref
Crossref
Peter H. Wiernik, Robert E. Gallagher & Martin S. Tallman. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
409
463
.
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
965
988
.
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
1
24
.
Yoshinori Tatemichi, Masahiko Shibazaki, Shinji Yasuhira, Shuya Kasai, Hiroshi Tada, Hiroki Oikawa, Yuji Suzuki, Yasuhiro Takikawa, Tomoyuki Masuda & Chihaya Maesawa. (2015)
Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through
SUMO
modification
. Cancer Science 106:7, pages 848-856.
Crossref
Crossref
Anahita Rafiei, Afsar Ali Mian, Claudia Döring, Anna Metodieva, Claudia Oancea, Frederic B. Thalheimer, Martin Leo Hansmann, Oliver Gerhard Ottmann & Martin Ruthardt. (2015) The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia. PLOS Genetics 11:4, pages e1005144.
Crossref
Crossref
Claudia Oancea, Brigitte Rüster, Boris Brill, Jessica Roos, Maria Heinssmann, Gesine Bug, Afsar Ali Mian, Nathalie Andrea Guillen, Steven M. Kornblau, Reinhard Henschler & Martin Ruthardt. (2014) STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML. Genes & Cancer 5:11-12, pages 378-392.
Crossref
Crossref
Jessica N. Nichol, Nicolas Garnier & Wilson H. MillerJr.Jr.. (2014) Triple A therapy: The molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide. Best Practice & Research Clinical Haematology 27:1, pages 19-31.
Crossref
Crossref
Peter H. Wiernik, Robert E. Gallagher & Martin S. Tallman. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
403
453
.
Sabine Beez, Philipp Demmer & Elena Puccetti. (2012) Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RARα and PLZF/RARα with Interfering Peptides. PLoS ONE 7:11, pages e48636.
Crossref
Crossref
Neil Hattersley, Linnan Shen, Ellis G. Jaffray & Ronald T. Hay. (2011) The SUMO protease SENP6 is a direct regulator of PML nuclear bodies. Molecular Biology of the Cell 22:1, pages 78-90.
Crossref
Crossref
Jessica Barry & Richard B. Lock. (2011) Small ubiquitin-related modifier-1: Wrestling with protein regulation. The International Journal of Biochemistry & Cell Biology 43:1, pages 37-40.
Crossref
Crossref
Ying-Li Wu, Hu-Chen Zhou & Guo-Qiang Chen. (2010) Molecular mechanisms of leukemia-associated protein degradation. Frontiers of Medicine in China 4:4, pages 363-370.
Crossref
Crossref
Yukiya Yamamoto, Sachiko Tsuzuki, Motohiro Tsuzuki, Kousuke Handa, Yoko Inaguma & Nobuhiko Emi. (2010) BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood 116:20, pages 4274-4283.
Crossref
Crossref
Antonello Mai. (2010) Small-molecule chromatin-modifying agents: therapeutic applications. Epigenomics 2:2, pages 307-324.
Crossref
Crossref
Hao Yuan, Jun Zhou, Min Deng, Xi Liu, Morgane Le Bras, Hugues de The, Sai Juan Chen, Zhu Chen, Ting Xi Liu & Jun Zhu. (2009) Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish. Cell Research 20:2, pages 185-196.
Crossref
Crossref
Patricia Mambou Gwanmesia, Annette Romanski, Kerstin Schwarz, Biserka Bacic, Martin Ruthardt & Oliver G Ottmann. (2009) The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines. BMC Cancer 9:1.
Crossref
Crossref
Susan Lösler, Sarah Schlief, Christiane Kneifel, Eckhard Thiel, Hubert Schrezenmeier & Markus T. Rojewski. (2009) Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system. Annals of Hematology 88:11, pages 1047-1058.
Crossref
Crossref
Apostolia Maria Tsimberidou, Luis H. Camacho, Srdan Verstovsek, Chaan Ng, David S. Hong, Cynthia K. Uehara, Catalina Gutierrez, Shawn Daring, Jan Stevens, Philip B. Komarnitsky, Brian Schwartz & Razelle Kurzrock. (2009) A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors. Clinical Cancer Research 15:14, pages 4769-4776.
Crossref
Crossref
John Rouse. (2009) Control of genome stability by Slx protein complexes. Biochemical Society Transactions 37:3, pages 495-510.
Crossref
Crossref
Naotaka Sekiyama, Takahisa Ikegami, Tsutomu Yamane, Mitsunori Ikeguchi, Yasuhiro Uchimura, Daichi Baba, Mariko Ariyoshi, Hidehito Tochio, Hisato Saitoh & Masahiro Shirakawa. (2008) Structure of the Small Ubiquitin-like Modifier (SUMO)-interacting Motif of MBD1-containing Chromatin-associated Factor 1 Bound to SUMO-3. Journal of Biological Chemistry 283:51, pages 35966-35975.
Crossref
Crossref
Lingna Li, Jie Wang, Richard D. Ye, Guiying Shi, Huifang Jin, Xueming Tang & Jing Yi. (2008) PML/RARα fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase. Journal of Cellular Physiology 217:2, pages 486-493.
Crossref
Crossref
Fernanda J. Cabral, Olavo S. PereiraJr.Jr., Camila S. Silva, Renata Guerra-Sá & Vanderlei Rodrigues. (2008) Schistosoma mansoni encodes SMT3B and SMT3C molecules responsible for post-translational modification of cellular proteins. Parasitology International 57:2, pages 172-178.
Crossref
Crossref
Michael H. Tatham, Marie-Claude Geoffroy, Linnan Shen, Anna Plechanovova, Neil Hattersley, Ellis G. Jaffray, Jorma J. Palvimo & Ronald T. Hay. (2008) RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nature Cell Biology 10:5, pages 538-546.
Crossref
Crossref
Soo Im Kang, Hae Woong Choi & Ick Young Kim. (2008) Redox-mediated modification of PLZF by SUMO-1 and ubiquitin. Biochemical and Biophysical Research Communications 369:4, pages 1209-1214.
Crossref
Crossref
Ying Huang, Jihui Qiu, Guoqiang Chen & Shuo Dong. (2008) Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARα, resulting in sequestration and decreased mobility of SMRT. Biochemical and Biophysical Research Communications 365:2, pages 258-265.
Crossref
Crossref
Sutisak Kitareewan, B. D. Roebuck, Eugene Demidenko, Roger D. Sloboda & Ethan Dmitrovsky. (2007) Lysosomes and Trivalent Arsenic Treatment in Acute Promyelocytic Leukemia. JNCI: Journal of the National Cancer Institute 99:1, pages 41-52.
Crossref
Crossref
Jiong Hu, Guang‐Biao Zhou, Zhen‐Yi Wang, Sai‐Juan Chen & Zhu Chen. 2007.
191
220
.
Olga Frankfurt, LoAnn C. Peterson, Robert Gallagher & Martin S. Tallman. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia
193
228
.
Padmaja Kunapuli, Chitta S. Kasyapa, Suet-Feung Chin, Carlos Caldas & John K. Cowell. (2006) ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML. Experimental Cell Research 312:19, pages 3739-3751.
Crossref
Crossref
Christina-Maria Hecker, Matthias Rabiller, Kaisa Haglund, Peter Bayer & Ivan Dikic. (2006) Specification of SUMO1- and SUMO2-interacting Motifs. Journal of Biological Chemistry 281:23, pages 16117-16127.
Crossref
Crossref
C. J. Lee, J. S. Han, C. Y. Seo, T. H. Park, H. C. Kwon, J. S. Jeong, I. H. Kim, J. Yun, Y. S. Bae, J. Y. Kwak & J. I. Park. (2006) Pioglitazone, a synthetic ligand for PPARγ, induces apoptosis in RB-deficient human colorectal cancer cells. Apoptosis 11:3, pages 401-411.
Crossref
Crossref
Xuemei Tian, Xiaodong Ma, Dongfang Qiao, Ande Ma, Fang Yan & Xingxu Huang. (2005) mCICR is required for As2O3-induced permeability transition pore opening and cytochrome c release from mitochondria. Molecular and Cellular Biochemistry 277:1-2, pages 33-42.
Crossref
Crossref
Wen-Chien Chou & Chi V Dang. (2005) Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Current Opinion in Hematology 12:1, pages 1-6.
Crossref
Crossref
Guo-Qiang Chen, Qiong Wang, Hua Yan & Zhu Chen. 2005. Natural Products. Natural Products
251
272
.
Ferhan Ayaydin & Mary Dasso. (2004)
Distinct In Vivo Dynamics of Vertebrate SUMO Paralogues
. Molecular Biology of the Cell 15:12, pages 5208-5218.
Crossref
Crossref
Felicity Z Watts. (2004) SUMO modification of proteins other than transcription factors. Seminars in Cell & Developmental Biology 15:2, pages 211-220.
Crossref
Crossref
Elena Puccetti, Tim Beissert, Saskia Güller, Jun E Li, Dieter Hoelzer, Oliver G Ottmann & Martin Ruthardt. (2003) Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis. Oncogene 22:44, pages 6900-6908.
Crossref
Crossref
Hiroshi Okano, Katsuya Shiraki, Hidekazu Inoue, Yutaka Yamanaka, Tomoyuki Kawakita, Yukiko Saitou, Yumi Yamaguchi, Naoyuki Enokimura, Norihiko Yamamoto, Kazushi Sugimoto, Kazumoto Murata & Takeshi Nakano. (2003) 15-Deoxy-Δ-12-14-PGJ2 Regulates Apoptosis Induction and Nuclear Factor-κB Activation Via a Peroxisome Proliferator-Activated Receptor-γ–Independent Mechanism in Hepatocellular Carcinoma. Laboratory Investigation 83:10, pages 1529-1539.
Crossref
Crossref
Anita R Mistry, Eva W Pedersen, Ellen Solomon & David Grimwade. (2003) The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Reviews 17:2, pages 71-97.
Crossref
Crossref
Alex Kentsis, Ronald E. Gordon & Katherine L. B. Borden. (2002) Control of biochemical reactions through supramolecular RING domain self-assembly. Proceedings of the National Academy of Sciences 99:24, pages 15404-15409.
Crossref
Crossref
Christian Récher, Martine Chopin, Emmanuel Raffoux, Gaëlle Pierron, Joël Poupon, François Sigaux, Hervé Dombret & Marc-Henri Stern. (2002)
In vitro
and
in vivo
effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia
. British Journal of Haematology 117:2, pages 343-350.
Crossref
Crossref
Sutisak Kitareewan, Ian Pitha-Rowe, David Sekula, Christopher H. Lowrey, Michael J. Nemeth, Todd R. Golub, Sarah J. Freemantle & Ethan Dmitrovsky. (2002) UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences 99:6, pages 3806-3811.
Crossref
Crossref
M. T. Rojewski, C. Baldus, W. Knauf, E. Thiel & H. Schrezenmeier. (2002)
Dual effects of arsenic trioxide (As
2
O
3
) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation
. British Journal of Haematology 116:3, pages 555-563.
Crossref
Crossref
Thomas G. Hofmann, Andreas Möller, Hüseyin Sirma, Hanswalter Zentgraf, Yoichi Taya, Wulf Dröge, Hans Will & M. Lienhard Schmitz. (2001) Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nature Cell Biology 4:1, pages 1-10.
Crossref
Crossref
Renaud MahieuxCynthia Pise-MasisonAntoine GessainJohn. N. BradyRené OlivierEmmanuelle PerretTom MisteliChristophe Nicot. (2001) Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1– and type 2–infected cells by a caspase-3–dependent mechanism involving Bcl-2 cleavage. Blood 98:13, pages 3762-3769.
Crossref
Crossref
Wen-Chien Chou, Anita L. Hawkins, John F. Barrett, Constance A. Griffin & Chi V. Dang. (2001) Arsenic inhibition of telomerase transcription leads to genetic instability. Journal of Clinical Investigation 108:10, pages 1541-1547.
Crossref
Crossref
Wen-Chien Chou, Anita L. Hawkins, John F. Barrett, Constance A. Griffin & Chi V. Dang. (2001) Arsenic inhibition of telomerase transcription leads to genetic instability. Journal of Clinical Investigation 108:10, pages 1541-1547.
Crossref
Crossref
Ting-Dong Zhang, Guo-Qiang Chen, Zhu-Gang Wang, Zhen-Yi Wang, Sai-Juan Chen & Zhu Chen. (2001) Arsenic trioxide, a therapeutic agent for APL. Oncogene 20:49, pages 7146-7153.
Crossref
Crossref
Gérard Benoit, Mathilde Roussel, Frédério Pendino, Evelyne Ségal-Bendirdjian & Michel Lanotte. (2001) Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation. Oncogene 20:49, pages 7161-7177.
Crossref
Crossref
Y Shen, Z-X Shen, H Yan, J Chen, X-Y Zeng, J-M Li, X-S Li, W Wu, S-M Xiong, W-L Zhao, W Tang, F Wu, Y-F Liu, C Niu, Z-Y Wang, S-J Chen & Z Chen. (2001) Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage. Leukemia 15:5, pages 735-741.
Crossref
Crossref
Jennifer BurkhamDonald M. Coen, Charles B. C. Hwang & Sandra K. Weller. (2001) Interactions of Herpes Simplex Virus Type 1 with ND10 and Recruitment of PML to Replication Compartments. Journal of Virology 75:5, pages 2353-2367.
Crossref
Crossref
Celia Donaghue, Helen Bates & Sue Cotterill. (2001) Identification and characterisation of the Drosophila homologue of the yeast Uba2 gene. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1518:1-2, pages 210-214.
Crossref
Crossref
Eduardo M. Rego, Zhu-Gang Wang, Daniela Peruzzi, Le-Zhen He, Carlos Cordon-Cardo & Pier Paolo Pandolfi. (2001) Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression. The Journal of Experimental Medicine 193:4, pages 521-530.
Crossref
Crossref
Eduardo M Rego & Pier Paolo Pandolfi. (2001) Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models. Seminars in Hematology 38:1, pages 54-70.
Crossref
Crossref
Chen Zhu, Chen Guo-Qiang, Shen Zhi-Xiang, Chen Sai-Juan & Wang Zhen-Yi. (2001) Treatment of acute promyelocytic leukemia with arsenic compounds: In vitro and in vivo studies. Seminars in Hematology 38:1, pages 26-36.
Crossref
Crossref
E Solary, N Droin, A Bettaieb, L Corcos, M-T Dimanche-Boitrel & C Garrido. (2000) Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. Leukemia 14:10, pages 1833-1849.
Crossref
Crossref
K Kitamura, Y Minami, K Yamamoto, Y Akao, H Kiyoi, H Saito & T Naoe. (2000) Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 14:10, pages 1743-1750.
Crossref
Crossref
Eduardo M. Rego, Li-Zhen He, Raymond P. WarrellJr.Jr., Zhu-Gang Wang & Pier Paolo Pandolfi. (2000)
Retinoic acid (RA) and As
2
O
3
treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARα and PLZF-RARα oncoproteins
. Proceedings of the National Academy of Sciences 97:18, pages 10173-10178.
Crossref
Crossref
Wen Jie Zhang, Kazunori Ohnishi, Hitoshi Yoshida, Ling Pan, Lola Maksumova, Farkhad Muratkhodjaev, Jian Min Luo, Kazuyuki Shigeno, Shinya Fujisawa, Kensuke Naito, Satoki Nakamura, Kaori Shinjo, Akihiro Takeshita & Ryuzo Ohno. (2000) Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down-regulation of Bcl-2 Expression and Modulation of Promyelocytic Leukemia Protein. Japanese Journal of Cancer Research 91:6, pages 604-611.
Crossref
Crossref
Kunio Kitamura, Shinetsu Hoshi, Mitsuru Koike, Hitoshi Kiyoi, Hidehiko Saito & Tomoki Naoe. (2000)
Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-
trans
retinoic acid
. British Journal of Haematology 108:4, pages 696-702.
Crossref
Crossref
Teruhiko Fujii, Marı́a Laura Garcı́a-Bermejo, Juan Lucas Bernabó, Jorge Caamaño, Motoi Ohba, Toshio Kuroki, Luowei Li, Stuart H. Yuspa & Marcelo G. Kazanietz. (2000) Involvement of Protein Kinase C δ (PKCδ) in Phorbol Ester-induced Apoptosis in LNCaP Prostate Cancer Cells. Journal of Biological Chemistry 275:11, pages 7574-7582.
Crossref
Crossref